Skip to main content
Top

Cancer and Metastasis Reviews

Issue 3-4/2001

Content (16 Articles)

Editorial Introduction

Editorial

Kenneth V. Honn, Avraham Raz

Molecular Profiling in Prostate Cancer

F. Feroze-Merzoug, M.S. Schober, Y.Q. Chen

Role of Eicosanoids in Prostate Cancer Progression

Daotai Nie, Mingxin Che, David Grignon, Keqin Tang, Kenneth V. Honn

Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression

Grant Buchanan, Ryan A. Irvine, Gerhard A. Coetzee, Wayne D. Tilley

Regulation of Apoptosis in Prostate Cancer

Sushma Gurumurthy, Krishna Murthi Vasudevan, Vivek M. Rangnekar

Metastasis Suppression in Prostate Cancer

Erich B. Jaeger, Rajeev S. Samant, Carrie W. Rinker-Schaeffer

Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities

Brian Nicholson, Greg Schaefer, Dan Theodorescu

Integrins and Prostate Cancer Metastases

Mara Fornaro, Thomas Manes, Lucia R. Languino

Prostate Carcinoma Skeletal Metastases: Cross-talk between Tumor and Bone

Evan T. Keller, Jian Zhang, Carlton R. Cooper, Peter C. Smith, Laurie K. McCauley, Kenneth J. Pienta, Russell S. Taichman

Signal Transduction Targets in Androgen-independent Prostate Cancer

Jian Zhou, Jessica Scholes, Jer-Tsong Hsieh

Volume Contents

Volume Contents

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine